Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)

[1] Jaferian S(2017)Stem cell, biomaterials and growth factors therapy for hepatocellular carcinoma Biomed Pharmacother 88 1046-1053

[2] Soleymaninejad M(2012)Should a radiological diagnosis of hepatocellular carcinoma be routinely confirmed by a biopsy? No Eur J Intern Med 23 37-39

[3] Negahdari B(2016)Parametric response mapping of contrast-enhanced biphasic CT for evaluation tumor viability of hepatocellular carcinoma after TACE Eur Radiol 26 3447-3455

[4] Eatemadi A(2017)Vascular invasion and metastasis is predictive of outcome in Barcelona clinic liver Cancer stage C hepatocellular carcinoma J Natl Compr Cancer Netw 15 197-204

[5] Heuman DM(2016)Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas Abdom Radiol (NY) 41 963-969

[6] Gilles HS(2018)LI-RADS 2017: An update J Magn Reson Imaging 47 1459-1474

[7] Solomom C(2018)CT-MRI LI-RADS v2017: a comprehensive guide for beginners J Clin Transl Hepatol 6 222-236

[8] Bajaj JS(2014)MR characterization of focal liver lesions: pearls and pitfalls Magn Reson Imaging Clin N Am 22 295-313

[9] Hinrichs JB(2014)CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. development, growth, and spread: key pathologic and imaging aspects Radiology 272 635-654

[10] Shin HO(2017)Quantitiative analysis of gadoxetic acid-enhanced magnetic resonance imaging predicts histological grade of hepatocellular carcinoma Clin Imaging 43 9-14

[1] Jaferian S(2017)Stem cell, biomaterials and growth factors therapy for hepatocellular carcinoma Biomed Pharmacother 88 1046-1053

[2] Soleymaninejad M(2012)Should a radiological diagnosis of hepatocellular carcinoma be routinely confirmed by a biopsy? No Eur J Intern Med 23 37-39

[3] Negahdari B(2016)Parametric response mapping of contrast-enhanced biphasic CT for evaluation tumor viability of hepatocellular carcinoma after TACE Eur Radiol 26 3447-3455

[4] Eatemadi A(2017)Vascular invasion and metastasis is predictive of outcome in Barcelona clinic liver Cancer stage C hepatocellular carcinoma J Natl Compr Cancer Netw 15 197-204

[5] Heuman DM(2016)Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas Abdom Radiol (NY) 41 963-969

[6] Gilles HS(2018)LI-RADS 2017: An update J Magn Reson Imaging 47 1459-1474

[7] Solomom C(2018)CT-MRI LI-RADS v2017: a comprehensive guide for beginners J Clin Transl Hepatol 6 222-236

[8] Bajaj JS(2014)MR characterization of focal liver lesions: pearls and pitfalls Magn Reson Imaging Clin N Am 22 295-313

[9] Hinrichs JB(2014)CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. development, growth, and spread: key pathologic and imaging aspects Radiology 272 635-654

[10] Shin HO(2017)Quantitiative analysis of gadoxetic acid-enhanced magnetic resonance imaging predicts histological grade of hepatocellular carcinoma Clin Imaging 43 9-14